GlaxoSmithKline’s drug aimed at chronic kidney disease patients with anaemia and AstraZeneca’s lung cancer treatment have both moved a step closer to getting the green light
World, Wide, News
Merkez mahallesi mutlu han sokak no:17/2 Bartın/Sakarya
info@thefamous.com.tr